Your browser doesn't support javascript.
loading
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy.
Ingrosso, G; Detti, B; Fodor, A; Caini, S; Borghesi, S; Triggiani, L; Trippa, F; Russo, D; Bruni, A; Francolini, G; Lancia, A; Marinelli, L; Di Muzio, N; Livi, L; Magrini, S M; Maranzano, E; Musio, D; Aristei, C; Valeriani, M.
Afiliação
  • Ingrosso G; Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy. ingrosso.gianluca@gmail.com.
  • Detti B; Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy.
  • Fodor A; Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy.
  • Caini S; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy.
  • Borghesi S; Unit of Radiation Oncology, S. Donato Hospital, Arezzo, Italy.
  • Triggiani L; Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
  • Trippa F; Department of Radiation Oncology, 'S. Maria' Hospital, Terni, Italy.
  • Russo D; Radiotherapy Unit, Ospedale "Vito Fazzi", Lecce, Italy.
  • Bruni A; Radiotherapy Unit, University Hospital of Modena, Modena, Italy.
  • Francolini G; Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy.
  • Lancia A; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Marinelli L; Department of Medicine and Surgery and Translational Medicine, "Sapienza" University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy.
  • Di Muzio N; Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy.
  • Livi L; Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy.
  • Magrini SM; Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
  • Maranzano E; Department of Radiation Oncology, 'S. Maria' Hospital, Terni, Italy.
  • Musio D; Radiotherapy Unit, Ospedale "Vito Fazzi", Lecce, Italy.
  • Aristei C; Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy.
  • Valeriani M; Department of Medicine and Surgery and Translational Medicine, "Sapienza" University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy.
Clin Transl Oncol ; 23(8): 1577-1584, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33495981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiocirurgia / Antagonistas de Receptores de Andrógenos / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiocirurgia / Antagonistas de Receptores de Andrógenos / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article